Medical device firm Bovie Medical has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its new J-Plasma generator and handpiece equipped with Cool-Coag technology.

Cool-Coag technology features J-Plasma's increased accuracy with minimal thermal spread combined with capabilities of standard monopolar coagulation and helium spray coagulation.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The combination allows use of a single device for greater control of tissue effect as well as an option to switch to a monopolar or helium spray coagulation mode with the push of a button.

"The development of Bovie’s Cool-Coag technology is a direct result of feedback from surgeons who have used our J-Plasma product for procedures that require greater coagulation capability."

Bovie Medical chief executive officer Robert Gershon said: "The development of Bovie’s Cool-Coag technology is a direct result of feedback from surgeons who have used our J-Plasma product for procedures that require greater coagulation capability, specifically in the areas of gynecologic oncology and surgical oncology.

“The unique flexibility of Cool-Coag enables the surgeon to use J-Plasma to perform the most delicate procedures, where precision and low-risk of injury to surrounding tissue are paramount and also have the full power of monopolar coagulation to control, pinpoint and diffuse bleeding as needed.”

See Also:

According to Memorial Sloan Kettering Cancer Center Ovarian Cancer Surgery head Dr Dennis Chi, the new technology has the potential to enhance the use of J-Plasma in several complex cancer procedures.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The device also facilitates usage close to vital structures with minimal collateral damage and standard full monopolar coagulation capability.

Estimated to be launched in the second half of this year, Cool-Coag  is expected to enable the use of J-Plasma in additional procedures and specialties.